Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Innate Pharma    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 273475468291291-
Entreprise Value (EV)1 163314268139255282
P/E ratio -5,34x149x-19,2x-5,23x-3,51x-7,84x
Yield ------
Capitalization / Revenue 6,20x5,06x5,45x3,40x4,37x3,83x
EV / Revenue 3,69x3,34x3,12x1,63x3,83x3,72x
EV / EBITDA -4,57x25,0x-25,5x-5,93x-5,07x-6,63x
Price to Book 3,00x2,61x1,83x1,25x1,92x1,80x
Nbr of stocks (in thousands) 57 43763 91478 54278 96378 963-
Reference price (EUR) 4,757,445,963,693,693,69
Last update 03/08/201803/20/201903/10/202012/18/202012/18/202012/18/2020
1 EUR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 44,094,085,885,766,676,0
EBITDA1 -35,612,5-10,5-23,5-50,3-42,6
Operating profit (EBIT)1 -40,05,15-27,1-35,3-64,2-59,1
Operating Margin -90,8%5,48%-31,5%-41,2%-96,4%-77,9%
Pre-Tax Profit (EBT)1 -48,02,72-20,8-21,7-52,8-76,4
Net income1 -48,43,05-20,8-30,8-63,8-50,5
Net margin -110%3,25%-24,2%-35,9%-95,8%-66,4%
EPS2 -0,890,05-0,31-0,70-1,05-0,47
Dividend per Share ------
Last update 03/08/201803/20/201903/10/2020---
1 EUR in Million
2 EUR
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 ------
Net Cash position1 11016120015236,18,63
Leverage (Debt / EBITDA) 3,10x-12,8x19,0x6,45x0,72x0,20x
Free Cash Flow1 -54,1-33,633,7-78,5-99,7-86,0
ROE (Net Profit / Equities) -56,2%2,41%-10,8%-7,34%-20,1%32,8%
Shareholders' equity1 86,1127192420317-154
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 1,582,853,252,941,922,05
Cash Flow per Share2 -0,570,25-0,08-1,60-1,50-0,20
Capex1 6,031,041,2725,324,880,3
Capex / Sales 13,7%1,11%1,48%29,5%37,2%106%
Last update 03/08/201803/20/201903/10/202012/18/202012/18/202012/18/2020
1 EUR in Million
2 EUR
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (EUR)
291 056 567
Capitalization (USD)
354 298 925
Net sales (EUR)
85 814 000
Net sales (USD)
104 427 057
Number of employees
247
Sales / Employee (EUR)
347 425
Sales / Employee (USD)
422 782
Free-Float
75,3%
Free-Float capitalization (EUR)
219 126 717
Free-Float capitalization (USD)
266 739 765
Avg. Exchange 20 sessions (EUR)
2 016 297
Avg. Exchange 20 sessions (USD)
2 453 631
Average Daily Capital Traded
0,69%
EPS & Dividend